BUILDING A NEW RESEARCH AND DEVELOPMENT LABORATORY OF QUINTA – ANALYTICA S.R.O. is co-financed by the European Union.

 

The aim of the project is to build a new research and development laboratory in Brno, which will significantly lead to the expansion of the existing research and innovation capacity (VIK). The project will create a top workplace equipped with the latest instruments and equipment for the analysis of medicinal products.

‍

Project Name: Rozšíření výzkumné a vývojové kapacity společnosti QUINTA-ANALYTICA, s.r.o.

Project Number: CZ.01.1.02/0.0/0.0/20_338/0023928

‍

EUROPEAN UNION

European Regional Development Fund

OP Enterprise and Innovation for Competitiveness

‍

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

ALL POSTS